*
Corresponding authors
a
Chemical Development, GlaxoSmithKline, 5 Moore Drive, Research Triangle Park, NC, USA
E-mail:
Susan.E.Barnes@gsk.com
b
Chemical Development, GlaxoSmithKline, Old Powder Mills, Leigh, Tonbridge, Kent, UK
c
Statistical Sciences, GlaxoSmithKline, 2301 Renaissance Blvd, King of Prussia, PA, USA
d
Chemical Development, GlaxoSmithKline, 709 Swedeland Road, King of Prussia, PA, USA
e
Global manufacturing and Supply, GlaxoSmithKline, Jurong, Singapore
f
CAMO Software Inc., One Woodbridge Center, Suite 319, Woodbridge, NJ, USA